Brief: Ryvu Therapeutics Reaches Second Milestone Under License Agreement With Exelixis

Ryvu Therapeutics SA

05/02/2024 07:04

Feb 5 (Reuters) - Ryvu Therapeutics SA  RVU.WA :
    * REACHES SECOND MILESTONE UNDER LICENSE AGREEMENT WITH
EXELIXIS
    * UNDER AGREEMENT COMPANY IS ELIGIBLE TO GET $2 MILLION OF
REMUNERATION FOR ACHIEVING SECOND MILESTONE
    * AGREEMENT TO DEVELOP TARGETED THERAPIES USING COMPANY-MADE
STING
TECHNOLOGY

Source text for Eikon:  ID:nEMbB6tpna 
Further company coverage:  RVU.WA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))